Gene: KIAA0232
Official Full Name: KIAA0232provided by HGNC
Gene Summary: Predicted to enable ATP binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32773 | KIAA0232 Knockout cell line (HeLa) | Human | KIAA0232 | 1:3~1:6 | Negative | Online Inquiry |
KO32774 | KIAA0232 Knockout cell line (HCT 116) | Human | KIAA0232 | 1:2~1:4 | Negative | Online Inquiry |
KO32775 | KIAA0232 Knockout cell line (HEK293) | Human | KIAA0232 | 1:3~1:6 | Negative | Online Inquiry |
KO32776 | KIAA0232 Knockout cell line (A549) | Human | KIAA0232 | 1:3~1:4 | Negative | Online Inquiry |
KIAA0232 Gene Knockout Cell Lines are specially developed cellular models that enable researchers to study the biological functions and pathological implications of the KIAA0232 gene, which is associated with various cellular processes and diseases. These cell lines are generated using advanced CRISPR-Cas9 technology, leading to precise disruptions in the gene, allowing for a comprehensive analysis of its role in cell proliferation, differentiation, and response to stress.
Functionally, KIAA0232 knockout cells provide a unique platform to explore the gene’s involvement in processes such as cellular signaling and metabolic regulation. By observing the phenotypic and molecular changes that occur in these modified cells, researchers can elucidate the underlying mechanisms of diseases where KIAA0232 is implicated, such as cancer or neurodegenerative disorders. This knockout model serves as an essential tool for pharmacological testing and biomarker discovery, enhancing our understanding of therapeutic targets.
The scientific importance of KIAA0232 Gene Knockout Cell Lines is underscored by their applicability in both fundamental research and clinical settings. They facilitate the development and testing of novel therapies, and contribute to the growing field of personalized medicine, where understanding individual genetic contributions to disease is crucial.
These cell lines offer distinct advantages over alternative models, as they provide a more relevant human cellular context compared to non-human or overexpression models. Moreover, the high specificity and efficiency of the CRISPR-Cas9 system assure researchers of the reliability and reproducibility of their findings, which are crucial for advancing scientific discovery.
For researchers and clinicians seeking to deepen their understanding of KIAA0232’s biological roles, these knockout cell lines present an invaluable resource. They enable precise experimental manipulations that can lead to significant breakthroughs in therapeutic development.
Our company is dedicated to providing cutting-edge biological products, and the KIAA0232 Gene Knockout Cell Lines exemplify our commitment to supporting the scientific community with reliable and innovative research tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.